Skip to main content
LB PHARMACEUTICALS INC logo

LB PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LBRX ISIN · US50180M1080 US Manufacturing
Filings indexed 88 across all filing types
Latest filing 2024-06-18 Regulatory Filings
Country US United States of America
Listing US LBRX

About LB PHARMACEUTICALS INC

https://lbpharma.us/

LB Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric diseases, with a primary emphasis on schizophrenia and bipolar depression. The company's pipeline is centered on its lead product candidate, LB-102, an oral small molecule. LB-102 is being developed as a potential first-in-class benzamide antipsychotic for approval in the United States. The company is advancing LB-102 through late-stage clinical development, including a Phase III trial for schizophrenia and a Phase II study for bipolar depression, to address significant unmet needs in mental healthcare.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-06-18 English
Regulatory Filings 2024
Regulatory Filings
2024-05-20 English
Regulatory Filings 2024
Regulatory Filings
2024-01-10 English
Regulatory Filings 2023
Regulatory Filings
2023-09-21 English
Regulatory Filings 2022
Regulatory Filings
2022-11-23 English
Regulatory Filings 2022
Regulatory Filings
2022-11-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.